Immunosens

About:

Immunosens is a medical device company that develops immunosensors for immunological tests.

Website: http://immunosens.com

Top Investors: Global Brain Corporation, Osaka University Venture Capital, Mehagen

Description:

Immunological is a developer of electrochemical measurement devices intended to evaluate biomarkers such as genes, proteins, and cell signals using electrode reactions.. The company's product uses disposable printable electrodes in its sensors, thereby providing health-care experts with accurate analysis and measurements in their diagnosis and food safety inspection tests.

Total Funding Amount:

315M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Suita, Osaka, Japan

Founded Date:

2018-01-25

Founders:

Hirokazu Sugihara

Number of Employees:

11-50

Last Funding Date:

2023-02-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai